[{"Assets_0_Q3_USD":382285.0,"CommonStockSharesOutstanding_0_Q3_shares":9533290.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-678508.0,"NetIncomeLoss_1_Q3_USD":-246171.0,"NetIncomeLoss_3_Q3_USD":-1957956.0,"StockholdersEquity_0_Q3_USD":-1606096.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":9533290.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":9533290.0,"Ticker":"ENOB","CIK":"1527728","name":"DANDRIT BIOTECH USA, INC.","OfficialName":"Enochian Biosciences Inc. Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"398960164.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170515"}]